Jacobs Levy Equity Management, Inc United Therapeutics Corp Transaction History

Jacobs Levy Equity Management, Inc

  • $25.8 Billion
  • Q4 2024

A detailed history of Jacobs Levy Equity Management, Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 2,268 shares of UTHR stock, worth $845,578. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,268
Previous 2,268 -0.0%
Holding current value
$845,578
Previous $812,000 1.48%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$210.76 - $249.51 $15.2 Million - $18 Million
-72,203 Reduced 96.95%
2,268 $521,000
Q4 2023

Feb 14, 2024
SELL
$214.88 - $256.94 $25.4 Million - $30.4 Million
-118,205 Reduced 61.35%
74,471 $16.4 Million
Q3 2023

Nov 16, 2023
SELL
$211.82 - $248.24 $6.75 Million - $7.91 Million
-31,881 Reduced 14.2%
192,676 $43.5 Million
Q2 2023

Aug 14, 2023
SELL
$205.19 - $232.99 $6.72 Million - $7.63 Million
-32,733 Reduced 12.72%
224,557 $49.6 Million
Q1 2023

May 15, 2023
SELL
$212.99 - $276.17 $13.2 Million - $17.1 Million
-61,753 Reduced 19.36%
257,290 $57.6 Million
Q4 2022

Feb 14, 2023
SELL
$205.95 - $280.43 $9.59 Million - $13.1 Million
-46,576 Reduced 12.74%
319,043 $88.7 Million
Q3 2022

Nov 15, 2022
BUY
$203.3 - $244.17 $7 Million - $8.4 Million
34,412 Added 10.39%
365,619 $76.6 Million
Q2 2022

Aug 15, 2022
SELL
$174.81 - $241.14 $2.51 Million - $3.46 Million
-14,369 Reduced 4.16%
331,207 $78 Million
Q1 2022

May 16, 2022
SELL
$166.16 - $213.96 $6.68 Million - $8.6 Million
-40,173 Reduced 10.41%
345,576 $62 Million
Q4 2021

Feb 14, 2022
SELL
$184.32 - $216.08 $18.8 Million - $22.1 Million
-102,263 Reduced 20.96%
385,749 $83.4 Million
Q3 2021

Nov 15, 2021
SELL
$179.86 - $214.88 $512,061 - $611,763
-2,847 Reduced 0.58%
488,012 $90.1 Million
Q2 2021

Aug 16, 2021
SELL
$170.47 - $211.93 $2.39 Million - $2.97 Million
-14,036 Reduced 2.78%
490,859 $88.1 Million
Q1 2021

May 17, 2021
BUY
$153.94 - $174.85 $302,030 - $343,055
1,962 Added 0.39%
504,895 $84.5 Million
Q4 2020

Feb 16, 2021
SELL
$101.87 - $151.79 $2.61 Million - $3.89 Million
-25,633 Reduced 4.85%
502,933 $76.3 Million
Q3 2020

Nov 16, 2020
BUY
$99.9 - $121.13 $7.72 Million - $9.36 Million
77,308 Added 17.13%
528,566 $53.4 Million
Q2 2020

Aug 17, 2020
BUY
$92.74 - $125.82 $8.04 Million - $10.9 Million
86,678 Added 23.77%
451,258 $54.6 Million
Q1 2020

May 15, 2020
BUY
$79.39 - $115.35 $22.1 Million - $32.1 Million
277,867 Added 320.44%
364,580 $34.6 Million
Q4 2019

Feb 14, 2020
BUY
$78.31 - $95.34 $6.13 Million - $7.46 Million
78,253 Added 924.98%
86,713 $7.64 Million
Q3 2019

Nov 14, 2019
BUY
$74.85 - $85.99 $633,231 - $727,475
8,460 New
8,460 $675,000

Others Institutions Holding UTHR

# of Institutions
722
Shares Held
60.9M
Call Options Held
123K
Put Options Held
104K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email